Specifically, C3G controls the secretion of pro- and anti-angiogenic factors from thrombin- or ADP-stimulated mouse platelets, which results in the modulation of angiogenesis, both in vivo and in vitro, including tumor angiogenesis and metastasis. This evidence concerns the gene RAPGEF1 and neoplasm.